PRESCRIBING · PART D · 2024
Total Rx claims
590
Beneficiaries
—
Total drug cost
$1.0M
Distinct drugs
22
Brand share
33.6%
Top prescribed drugs
Baclofen90 claims
Gabapentin67 claims
Pregabalin48 claims
Dalfampridine31 claims
Tizanidine Hcl30 claims
QUALITY · MIPS · 2024
Final MIPS score
81.3
Quality
66.4
Cost
71.4
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.27%
Group
CROSS-REFERENCE